Expanding care for perinatal women with depression (EXPONATE): study protocol for a randomized controlled trial of an intervention package for perinatal depression in primary care

BMC Psychiatry

Danielle Groleau¹  Phyllis Zelkowitz¹  Laurence Kirmayer¹  Lola Kola²  Alan A. Montgomery³  Ricardo Araya⁴  Bibilola Damilola Oladeji²  Oye Gureje² 

[1] Division of Social and Transcultural Psychiatry, McGill University Culture and Mental Health research unit, Jewish General Hospital, Montréal, Canada;Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria;Nottingham Clinical Trials Unit, University of Nottingham, Queen’s Medical Centre, Nottingham, UK;Centre for Global Mental Health, London School of Hygiene and Tropical Medicine, London, UK

关键词: Cluster randomized trial;    Primary care;    Perinatal depression;   

Others  :  1217932
DOI  :  10.1186/s12888-015-0537-3

 received in 2015-05-29, accepted in 2015-06-22,  发布年份 2015

【 摘 要 】

Background

Depression is common among women during perinatal period and is associated with long-term adverse consequences for the mother and infant. In Nigeria, as in many other low- and-middle-income countries (LMIC), perinatal depression usually goes unrecognized and untreated. The aim of EXPONATE is to test the effectiveness and cost-effectiveness of an intervention package for perinatal depression delivered by community midwives in primary maternal care in which physician support and enhanced patient compliance are implemented using mobile phones.

Methods/Study design

A pragmatic two-arm parallel cluster randomized controlled trial was designed. The units of allocation are the primary maternal care clinics. Thirty eligible and consenting clinics were randomized but, due to problems with logistics, 29 eventually participated. Consenting pregnant women with a gestational age between 16 and 28 weeks who screened positive on the Edinburgh Postnatal Depression Scale (EPDS score ≥12), absent psychosis or bipolar disorder, and not actively suicidal were recruited into the trial (N = 686). Midwives in the intervention arm were trained to deliver psychoeducation, problem solving treatment, and parenting skills. Eight weekly sessions were delivered following entry into the study. Further sessions during pregnancy and 6 weeks following childbirth were determined by level of depressive symptoms. Clinical support and supervision, delivered mainly by mobile phone, were provided by general physicians and psychiatrists. Automated text and voice messages, also delivered by mobile phones, were used to facilitate patient compliance with clinic appointments and ‘homework’ tasks. Patients in the control arm received care as usual enhanced by further training of the providers in that arm in the recognition and standard treatment of depression. Assessments are undertaken at baseline, 2 months following recruitment into the study and 3, 6, 9 and 12 months after childbirth. The primary outcome is recovery from depression (EPDS < 6) at 6 months. Secondary outcomes include measures of disability, parenting skills, maternal attitudes, health care utilization as well as infant physical and cognitive development comprehensively assessed using the Bayley’s Scales.

Discussion

To the best of our knowledge, this is the largest randomized controlled trial of an intervention package delivered by community midwives in sub-Saharan Africa.

Trial registration

Trial is registered with the ISRTCN registry at isrtcn.com; Trial number ISRCTN60041127. Date of registration is 15/05/2013.

【 授权许可】

   
2015 Gureje et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]Ustun TB, Ayuso-Mateos JL, Chatterj S, Mathers C, Murray CJL: Global burden of depressive disorder in the year 2000. Br J Psychiatry 2004, 184:386-392.
• [2]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006., 3Article ID e442
• [3]Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997, 349(9063):1436-1442.
• [4]Abiodun OA: A study of mental morbidity among primary care patients in Nigeria. Compr Psychiatry 1993, 34(1):10-13.
• [5]Gureje O, Odejide OA, Olatawura MO, Ikuesan A, Acha RA, Bamidele RW, et al.: Psychological Problems in General Health Care: Results from the Ibadan Centre. Wiley, London; 1995.
• [6]Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T: Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005, 106(5 Pt 1):1071-1083.
• [7]Abiodun OA: Postnatal depression in primary care populations in Nigeria. Gen Hosp Psychiatry 2006, 28:133-136.
• [8]Adewuya AO, Ola BA, Aloba OO, Dada AO, Fasoto OO: Prevalence and correlates of depression in late pregnancy among Nigerian women. Depress Anxiety 2007, 24(1):15-21.
• [9]Aderibigbe YA, Gureje O: The validity of the 28-item General Health Questionnaire in a Nigerian antenatal clinic. Soc Psychiatry Psychiatr Epidemiol 1992, 27(6):280-283.
• [10]Aderibigbe YA, Gureje O, Omigbodun O: Postnatal emotional disorders in Nigerian women: a study of antecedents and associations. Br J Psychiatry 1993, 163:645-650.
• [11]Uwakwe R: Affective (depressive) morbidity in puerperal Nigerian women: validation of the Edinburgh postnatal depression scale. Acta Psychiatr Scand 2003, 107(4):251-259.
• [12]Patel V, Rahman A, Jacob KS, Hughes M: Effect of maternal mental health on infant growth in low income countries: new evidence from South Asia. BMJ 2004, 328(7443):820-823.
• [13]Bonari L, Pinto N, Ahn E, Einarson A, Steiner M, Koren G: Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 2004, 49(11):726-735.
• [14]Lobel M, Dunkel-Schetter C, Scrimshaw SC: Prenatal maternal stress and prematurity: a prospective study of socioeconomically disadvantaged women. Health Psychol 1992, 11(1):32-40.
• [15]Lou HC, Hansen D, Nordentoft M, Pryds O, Jensen F, Nim J, et al.: Prenatal stressors of human life affect fetal brain development. Dev Med Child Neurol 1994, 36(9):826-832.
• [16]Adewuya AO, Ola BA, Aloba OO, Mapayi BM, Okeniyi JA: Impact of postnatal depression on infants growth in Nigeria. J Affect Disord 2008, 108:191-193.
• [17]Rahman A, Iqbal Z, Bunn J, Lovel H, Harrington R: Impact of maternal depression on infant nutritional status and illness: a cohort study. Arch Gen Psychiatry 2004, 61(9):946-952.
• [18]Murray L: The impact of postnatal depression. J Child Psychol Psychiatry 1992, 33:543-561.
• [19]Stein A, Gath D, Bucher J, Bond A, Day A, Cooper PJ. The relationship between postnatal depression and mother-child interaction. Br J Psychiatry. 1991;158:46–52.
• [20]Martins C, Gaffan EA: Effects of early maternal depression on patterns of infant-mother attachment: a meta-analytical investigation. J Child Psychol Psychiatry 2000, 6:737-746.
• [21]Wang PS, Aguillar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al.: Use of mental health services for anxiety, mood and substance use disorders in 17 countries in the WHO World Mental Health Surveys. Lancet 2007, 370:841-850.
• [22]Hearn G, Hiff A, Jones A, Ormiston P, Parr P, Rout J, et al.: Postnatal depression in the community. BJGP 1998, 48:1064-1066.
• [23]World Health Organization: Mental Health Atlas. World Health Organization, Geneva; 2005.
• [24]Petersen I, Lund C, Stein DJ: Optimizing mental health services in low-income and middle-income countries. Curr Opin Psychiatry 2011, 24:318-323.
• [25]Morrell CJ, Slade P, Warner R, Paley G, Dixon S, Walters SJ, et al.: Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. Br Med J 2009, 338:a3045.
• [26]Roman LA, Gardiner JC, Lindsay JK, Moore JS, Luo Z, Baer LJ, et al.: Alleviating perinatal depressive symptoms and stress: a nurse-community health worker randomized trial. Arch Womens Ment Health 2009, 12(6):379-391.
• [27]Patel V, Kirkwood B: Perinatal depression treated by community health workers. Lancet 2008, 372(9642):868-869.
• [28]Rojas G, Fritsch R, Solis J, Jadresic E, Castillo C, Gonzalez M, et al.: Treatment of postnatal depression in low-income mothers in primary care clinics in Santiago, Chile: a randomized controlled trial. Lancet 2007, 370(9599):1629-1637.
• [29]Rahman A, Malik A, Sikander S, Roberts C, Creed F: Cognitive behavior therapy-based intervention by community health workers for mothers with depression and their infants in rural Pakistan: a cluster-randomized controlled trial. Lancet 2008, 372(9642):902-909.
• [30]Patel V, Weiss HA, Chowdhary N, Naik S, Pednekar S, Chatterjee S, et al.: Effectiveness of an intervention led by lay health counsellors for depressive and anxiety disorders in primary care in Goa, India (MANAS): a cluster randomized controlled trial. Lancet 2010, 376:2086-2095.
• [31]Uwakwe R: Affective (depressive) morbidity in puerperal women: validation of the EPDS. Acta Psychiatrica Scandinavia 2003, 107:251-259.
• [32]Kessler RC, Calabrese JR, Farley PA, Gruber MJ, Jewell MA, Katon W, et al.: Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med 2013, 43(08):1625-1637.
• [33]Oladeji BD, Kola L, Abiona T, Montgomery AA, Araya R, Gureje O: A pilot randomized controlled trial of a stepped care intervention package for depression in primary care in Nigeria. BMC Psychiatry 2015, 15:96. BioMed Central Full Text
• [34]Abdulmalik J, Kola L, Fadahunsi W, Adebayo K, Yasamy MT, Musa E, et al.: Country contextualization of the mental health gap action programme intervention guide: a case study from Nigeria. PLoS Med 2013., 10(8) Article ID e1001501
• [35]Chibanda D, Mesu P, Kajawu L, Cowan F, Araya R, Abas MA: Problem-solving therapy for depression and common mental disorders in Zimbabwe: piloting a task-shifting primary mental health care intervention in a population with a high prevalence of people living with HIV. BMC Public Health 2011, 11:828. BioMed Central Full Text
• [36]Mynors-Wallis LM, Gath D, Lloyd-Thomas AR, Tomlinson D: Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995, 310:441-445.
• [37]Ustun TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al.: Developing the World Health Organization disability assessment schedule 2.0. Bull World Health Organ 2010, 88:815-823.
• [38]von Korff M, Crane PK, Alonso J, Vilagut G, Angermeyer MC, Bruffaerts R, et al.: Modifications to the WHODAS-II for the world mental health surveys: implications of filter items. J Clin Epidemiol 2008, 61(11):1132-1143.
• [39]Kumar R, Robson K, Smith A: Development of a self-administered questionnaire to measure maternal adjustment and attitudes during pregnancy and after delivery. J Psychosom Res 1984, 28:43-51.
• [40]Bradley RH: Children’s home environments, health, behavior, and intervention efforts: a review using the HOME inventory as a marker measure. Genet Soc Gen Psychol Monogr 1993, 119:437-490.
• [41]Lasalvia A, Zoppei S, Van Bortel T, Bonetto C, Cristofalo D, Wahlbeck K, et al.: Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey. Lancet 2013, 381(9860):55-62.
• [42]Chisholm D, Conroy S, Glangeaud-Freudenthal N, Oates MR, Asten P, Barry S, et al.: Health services research into postnatal depression: results from a preliminary cross-cultural study. Br J Psychiatry 2004, 184(suppl. 46):s45-s52.
• [43]Gureje O, Chisholm D, Kola L, Lasebikan VO, Saxena S: Cost effectiveness of an essential mental health intervention package in Nigeria. World Psychiatry 2007, 6:42-48.
• [44]Bayley N: Bayley Scales of Infant Development. 2nd edition. The Psychological Corporation, San Antonio, USA; 1993.
• [45]Aina OF, Morakinyo O: Normative data on mental and motor development in Nigerian children. West Afr J Med 2005, 24(2):151-156.
• [46]Schulz KF, Altman DG, Moher D: The CONSORT Group: CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials 2010, 11:32. BioMed Central Full Text
• [47]Campbell MK, Piaggio G, Elbourne DR, Altman DG: Consort 2010 statement: extension to cluster randomised trials. BMJ 2012, 345:e5661.